Unisec

UNISEC Press releases


2018

• BiondVax and European UNISEC Consortium to Host Universal Flu Vaccine Conference
February 8, 2018
Link 


2017

• BiondVax Reports Positive Phase 2b Clinical Trial Results for its Universal Flu Vaccine
July 20, 2017
Link 


2016

• BiondVax Phase 2b Trial Preliminary Safety Results: The Universal Flu Vaccine candidate is safe and well tolerated
November 29, 2016
Link 

• BiondVax Phase 2b European Trial: Last Patient Out
September 21, 2016
Link 

• BiondVax’s Universal Flu Vaccine Phase 2b Clinical Trial Recruitment Complete
March 28, 2016
Link 


2015

• BiondVax Announces Successful Recruitment of the First Participants in a Phase IIb Clinical Trial in Europe with its Universal Flu Vaccine: Multimeric M-001
October 21, 2015
Link 

• UNISEC Press Release: UNISEC consortium including BiondVax started a clinical trial for a Universal Influenza Vaccine
16 October 2015
Link 

• BiondVax Initiates a Phase IIb Clinical Trial in Europe for its Universal Flu Vaccine for Pandemic Outbreak
September 30, 2015
Link